Neo Ivy Capital Management - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$264
+1289.5%
11,800
+2437.6%
0.12%
+1060.0%
Q2 2023$19
-91.9%
465
-92.4%
0.01%
-93.7%
Q4 2022$234
-99.8%
6,132
+106.5%
0.16%
-50.0%
Q2 2022$118,000
+76.1%
2,969
+124.9%
0.32%
+310.4%
Q3 2021$67,000
-94.4%
1,320
-95.0%
0.08%
-83.0%
Q2 2020$1,197,000
+2502.2%
26,434
+2471.4%
0.45%
+502.7%
Q1 2020$46,000
-40.3%
1,028
-36.3%
0.08%
-15.7%
Q4 2019$77,000
-93.2%
1,613
-93.6%
0.09%
-86.0%
Q2 2019$1,130,00025,1140.64%
Other shareholders
PTC THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders